12886_2019_1251_MOESM2_ESM.docx (36.62 kB)
MOESM2 of Functional versus functional and anatomical criteria-guided ranibizumab treatment in patients with neovascular age-related macular degeneration – results from the randomized, phase IIIb OCTAVE study
journal contribution
posted on 2020-01-10, 04:53 authored by Giovanni Staurenghi, Justus Garweg, Bianca Gerendas, Wayne Macfadden, Boris Gekkiev, Philippe Margaron, Cornelia Dunger-Baldauf, Petr KolarAdditional file 2. Exclusion criteria.